•  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Nu-Med Plus
  •  Nitric Oxide
  •  Products
  •  Innovation
  •  Investors
  •  Connect

Nu-Med Plus Inc. Announces Patent Approval Notification For Low Cost Nitric Oxide Technology

Posted on June 27, 2017June 14, 2019
Posted in Investor News

Post navigation

Nu-Med Plus Selects Houlihan Advisors to Valuate Company
Nu-Med Plus, Inc. Selects Salient Technologies, Inc. for Go to Market Design of Nitric Oxide Medical Device for FDA Submission

Connect

Jeff Robins | CEO
jeff@nu-medplus.com
801.746.3570
LinkedIn
Twitter

Offices

Corporate 455 E. 500 S.
Suite #203
Salt Lake City UT, 84111

Lab 1266 S 1380 W
Orem UT, 84111

News

Stay Up to Date On Nu-Med Plus News

Legal

SEC Documents Shareholder Letters Privacy Policy

Crunchbase

Profile

© 2022 Nu-Med Plus All Rights Reserved

Site designed + built by Wildern